Traumatic brain injuries assessment Market By End-user, By Diagnostic Type (CT-Scan, MRI, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global traumatic brain injuries assessment market size was $9,570 million in 2021 and is predicted to expand at a CAGR of 7.0% % by generating a revenue of $18,373.6 million by 2031.

Traumatic brain injuries assessment market growth is a significant public health issue in India. They contribute to the demise, harm, and disabling of young, active members of society. India suffers huge economic losses due to TBIs, yet they are unquantifiable. TBIs will rise in India as it moves toward greater growth and development in terms of motorization and urbanization. The World Health Organization's recent world reports on road traffic injury prevention and violence &health make clear how serious the problem of injuries is getting around the world and how urgently programs for prevention, management, and rehabilitation need to be designed and evaluated. India is one nation that has not prioritized prevention.

TBIs negatively affect executive function and self-control. The ability to control stress- and anxiety-related behavior is known as self-regulation. For someone with a TBI, this can involve difficulty settling down, difficulty waiting their turn, or having overpowering emotions in strange settings. Executive functioning refers to higher-order brain functions that are involved in planning, recalling, setting goals, focusing attention, and obeying directions. TBI sufferers may easily become disoriented or forget things, and they may find it challenging to learn new information, complete paperwork, or use public transportation.

The adoption of the most recent technologies and the launch of new products by market participants are expected to accelerate market expansion during the forecast period. For instance, Bio Direction, Inc.'s NanoDx system is a quick point-of-care (POC) diagnostic that accurately diagnoses concussions/TBIs in under two minutes.

The study, which is being funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), is still in progress, but preliminary findings indicate that the pandemic has a significant impact on those who have had brain injuries, including social isolation, disruption of daily life, and effects on cognition. The Administration for Community Living-funded Traumatic Brain Damage Technical Assistance and Resource Center (TBI TARC) set out to further study how COVID-19 has affected people with brain injuries. The TBI Advisory and Leadership (TAL) group's five members were questioned by the TBI TARC. The TAL group's goal is to direct TBI TARC's priorities.

The key players profiled in this report include: Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the traumatic brain injuries assessment market analysis from 2021 to 2031 to identify the prevailing traumatic brain injuries assessment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the traumatic brain injuries assessment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global traumatic brain injuries assessment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End-user

Hospital
Diagnostics Center
Others

By Diagnostic Type

CT-Scan
MRI
Intracranial Pressure Monitoring
Partial Pressure of Oxygen in Brain Tissue (pBrO2)
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA

Key Market Players

brainscope company inc.
NOVASIGNAL CORPORATION
Integra LifeSciences Holdings Corporation
Natus Medical Incorporated
Boston Scientific Corporation
Koninklijke Philips N.V.
BioDirection, Inc.
Nihon Kohden Corp.
RAUMEDIC AG
Compumedics Ltd.

Product Code: A31382

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.2.Restraints
- 3.4.3.Opportunities
3.5.COVID-19 Impact Analysis on the market
3.6.Value Chain Analysis
3.7.Key Regulation Analysis
3.8.Patent Landscape
3.9.Regulatory Guidelines
3.10.Market Share Analysis

CHAPTER 4: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER

4.1 Overview
- 4.1.1 Market size and forecast
4.2. Hospital
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3. Diagnostics Center
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
4.4. Others
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country

CHAPTER 5: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2. CT-Scan
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3. MRI
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
5.4. Intracranial Pressure Monitoring
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
5.5. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
5.6. Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country

CHAPTER 6: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by End-user
- 6.2.3 North America Market size and forecast, by Diagnostic Type
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Key market trends, growth factors and opportunities
  - 6.2.4.1.2 Market size and forecast, by End-user
  - 6.2.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Key market trends, growth factors and opportunities
  - 6.2.4.2.2 Market size and forecast, by End-user
  - 6.2.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Key market trends, growth factors and opportunities
  - 6.2.4.3.2 Market size and forecast, by End-user
  - 6.2.4.3.3 Market size and forecast, by Diagnostic Type
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by End-user
- 6.3.3 Europe Market size and forecast, by Diagnostic Type
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Key market trends, growth factors and opportunities
  - 6.3.4.1.2 Market size and forecast, by End-user
  - 6.3.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.2 UK
  - 6.3.4.2.1 Key market trends, growth factors and opportunities
  - 6.3.4.2.2 Market size and forecast, by End-user
  - 6.3.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.3 France
  - 6.3.4.3.1 Key market trends, growth factors and opportunities
  - 6.3.4.3.2 Market size and forecast, by End-user
  - 6.3.4.3.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.4 Spain
  - 6.3.4.4.1 Key market trends, growth factors and opportunities
  - 6.3.4.4.2 Market size and forecast, by End-user
  - 6.3.4.4.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.5 Italy
  - 6.3.4.5.1 Key market trends, growth factors and opportunities
  - 6.3.4.5.2 Market size and forecast, by End-user
  - 6.3.4.5.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.6 Rest of Europe
  - 6.3.4.6.1 Key market trends, growth factors and opportunities
  - 6.3.4.6.2 Market size and forecast, by End-user
  - 6.3.4.6.3 Market size and forecast, by Diagnostic Type
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by End-user
- 6.4.3 Asia-Pacific Market size and forecast, by Diagnostic Type
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 China
  - 6.4.4.1.1 Key market trends, growth factors and opportunities
  - 6.4.4.1.2 Market size and forecast, by End-user
  - 6.4.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.2 Japan
  - 6.4.4.2.1 Key market trends, growth factors and opportunities
  - 6.4.4.2.2 Market size and forecast, by End-user
  - 6.4.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.3 India
  - 6.4.4.3.1 Key market trends, growth factors and opportunities
  - 6.4.4.3.2 Market size and forecast, by End-user
  - 6.4.4.3.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.4 South Korea
  - 6.4.4.4.1 Key market trends, growth factors and opportunities
  - 6.4.4.4.2 Market size and forecast, by End-user
  - 6.4.4.4.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.5 Australia
  - 6.4.4.5.1 Key market trends, growth factors and opportunities
  - 6.4.4.5.2 Market size and forecast, by End-user
  - 6.4.4.5.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.6 Rest of Asia-Pacific
  - 6.4.4.6.1 Key market trends, growth factors and opportunities
  - 6.4.4.6.2 Market size and forecast, by End-user
  - 6.4.4.6.3 Market size and forecast, by Diagnostic Type
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by End-user
- 6.5.3 LAMEA Market size and forecast, by Diagnostic Type
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Brazil
  - 6.5.4.1.1 Key market trends, growth factors and opportunities
  - 6.5.4.1.2 Market size and forecast, by End-user
  - 6.5.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.2 Saudi Arabia
  - 6.5.4.2.1 Key market trends, growth factors and opportunities
  - 6.5.4.2.2 Market size and forecast, by End-user
  - 6.5.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.3 UAE
  - 6.5.4.3.1 Key market trends, growth factors and opportunities
  - 6.5.4.3.2 Market size and forecast, by End-user
  - 6.5.4.3.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.4 South Africa
  - 6.5.4.4.1 Key market trends, growth factors and opportunities
  - 6.5.4.4.2 Market size and forecast, by End-user
  - 6.5.4.4.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.5 Rest of LAMEA
  - 6.5.4.5.1 Key market trends, growth factors and opportunities
  - 6.5.4.5.2 Market size and forecast, by End-user
  - 6.5.4.5.3 Market size and forecast, by Diagnostic Type

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

8.1 brainscope company inc.
- 8.1.1 Company overview
- 8.1.2 Key Executives
- 8.1.3 Company snapshot
- 8.1.4 Operating business segments
- 8.1.5 Product portfolio
- 8.1.6 Business performance
- 8.1.7 Key strategic moves and developments
8.2 NOVASIGNAL CORPORATION
- 8.2.1 Company overview
- 8.2.2 Key Executives
- 8.2.3 Company snapshot
- 8.2.4 Operating business segments
- 8.2.5 Product portfolio
- 8.2.6 Business performance
- 8.2.7 Key strategic moves and developments
8.3 Integra LifeSciences Holdings Corporation
- 8.3.1 Company overview
- 8.3.2 Key Executives
- 8.3.3 Company snapshot
- 8.3.4 Operating business segments
- 8.3.5 Product portfolio
- 8.3.6 Business performance
- 8.3.7 Key strategic moves and developments
8.4 Natus Medical Incorporated
- 8.4.1 Company overview
- 8.4.2 Key Executives
- 8.4.3 Company snapshot
- 8.4.4 Operating business segments
- 8.4.5 Product portfolio
- 8.4.6 Business performance
- 8.4.7 Key strategic moves and developments
8.5 Boston Scientific Corporation
- 8.5.1 Company overview
- 8.5.2 Key Executives
- 8.5.3 Company snapshot
- 8.5.4 Operating business segments
- 8.5.5 Product portfolio
- 8.5.6 Business performance
- 8.5.7 Key strategic moves and developments
8.6 Koninklijke Philips N.V.
- 8.6.1 Company overview
- 8.6.2 Key Executives
- 8.6.3 Company snapshot
- 8.6.4 Operating business segments
- 8.6.5 Product portfolio
- 8.6.6 Business performance
- 8.6.7 Key strategic moves and developments
8.7 BioDirection, Inc.
- 8.7.1 Company overview
- 8.7.2 Key Executives
- 8.7.3 Company snapshot
- 8.7.4 Operating business segments
- 8.7.5 Product portfolio
- 8.7.6 Business performance
- 8.7.7 Key strategic moves and developments
8.8 Nihon Kohden Corp.
- 8.8.1 Company overview
- 8.8.2 Key Executives
- 8.8.3 Company snapshot
- 8.8.4 Operating business segments
- 8.8.5 Product portfolio
- 8.8.6 Business performance
- 8.8.7 Key strategic moves and developments
8.9 RAUMEDIC AG
- 8.9.1 Company overview
- 8.9.2 Key Executives
- 8.9.3 Company snapshot
- 8.9.4 Operating business segments
- 8.9.5 Product portfolio
- 8.9.6 Business performance
- 8.9.7 Key strategic moves and developments
8.10 Compumedics Ltd.
- 8.10.1 Company overview
- 8.10.2 Key Executives
- 8.10.3 Company snapshot
- 8.10.4 Operating business segments
- 8.10.5 Product portfolio
- 8.10.6 Business performance
- 8.10.7 Key strategic moves and developments